Literature DB >> 2175756

Detection of human papillomavirus type 16 DNA in carcinomas of the palatine tonsil.

G Niedobitek1, S Pitteroff, H Herbst, P Shepherd, T Finn, I Anagnostopoulos, H Stein.   

Abstract

Twenty eight tonsillar carcinomas of various histological types were investigated for the presence of Epstein-Barr virus (EBV), cytomegalovirus (CMV), and human papillomavirus (HPV) types 6, 11, and 16 by in situ hybridisation using highly stringent procedures. In six cases an autoradiographic signal was obtained in the tumour cell nuclei with the HPV type 16 specific probe. No signal was obtained with any of the other probes. Immunohistochemical investigations with mouse monoclonal antibodies directed against the L1 protein of HPV type and a rabbit antiserum that detects common protein determinants of HPV gave negative results, thus indicating latent infection. Furthermore, a series of tonsils from controls with comparable age distribution was negative by both in situ hybridisation and immunohistology. These results indicate a possible role for HPV 16 in the aetiology of a proportion of tonsillar carcinomas.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2175756      PMCID: PMC502902          DOI: 10.1136/jcp.43.11.918

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  25 in total

1.  In situ hybridization analysis of HPV 16 DNA sequences in early cervical neoplasia.

Authors:  C P Crum; N Nagai; R U Levine; S Silverstein
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

2.  Detection of human papillomavirus DNA in invasive carcinomas of the cervix by in situ hybridization.

Authors:  R S Ostrow; D A Manias; B A Clark; T Okagaki; L B Twiggs; A J Faras
Journal:  Cancer Res       Date:  1987-01-15       Impact factor: 12.701

3.  Identification of immunogenic regions of the major coat protein of human papillomavirus type 16 that contain type-restricted epitopes.

Authors:  J Cason; D Patel; J Naylor; D Lunney; P S Shepherd; J M Best; D J McCance
Journal:  J Gen Virol       Date:  1989-11       Impact factor: 3.891

4.  Characterization of integrated human papillomavirus type 11 DNA in primary and metastatic tumors from a renal transplant recipient.

Authors:  D A Manias; R S Ostrow; R C McGlennen; R D Estensen; A J Faras
Journal:  Cancer Res       Date:  1989-05-01       Impact factor: 12.701

5.  Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma: dissociation between phenotype and genotype.

Authors:  H Herbst; G Tippelmann; I Anagnostopoulos; J Gerdes; R Schwarting; T Boehm; S Pileri; D B Jones; H Stein
Journal:  Leuk Res       Date:  1989       Impact factor: 3.156

6.  Detection of viral genomes in the liver by in situ hybridization using 35S-, bromodeoxyuridine-, and biotin-labeled probes.

Authors:  G Niedobitek; T Finn; H Herbst; H Stein
Journal:  Am J Pathol       Date:  1989-03       Impact factor: 4.307

7.  Association of papillomavirus with cancers of the head and neck.

Authors:  J L Brandsma; A L Abramson
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1989-05

8.  Association of the Epstein-Barr virus with lymphoepithelioma of the thymus.

Authors:  I W Dimery; J S Lee; M Blick; G Pearson; G Spitzer; W K Hong
Journal:  Cancer       Date:  1988-06-15       Impact factor: 6.860

Review 9.  Tonsil cancer.

Authors:  F P Bopp; J A White
Journal:  J La State Med Soc       Date:  1989-04

Review 10.  Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence.

Authors:  N Muñoz; X Bosch; J M Kaldor
Journal:  Br J Cancer       Date:  1988-01       Impact factor: 7.640

View more
  20 in total

1.  Cervical cancer.

Authors:  P J van Diest; H Holzel
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

Review 2.  The role of HPV in head and neck cancer and review of the HPV vaccine.

Authors:  Gypsyamber D'Souza; Amanda Dempsey
Journal:  Prev Med       Date:  2011-10       Impact factor: 4.018

3.  HUMAN PAPILLOMAVIRUS ASSOCIATION WITH HEAD AND NECK CANCERS: UNDERSTANDING VIRUS BIOLOGY AND USING IT IN THE DEVELOPMENT OF CANCER DIAGNOSTICS.

Authors:  Katerina Strati; Paul F Lambert
Journal:  Expert Opin Med Diagn       Date:  2008-01-01

Review 4.  Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination.

Authors:  Maura L Gillison
Journal:  J Adolesc Health       Date:  2008-10       Impact factor: 5.012

5.  Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany.

Authors:  Franziska Hauck; Michelle Oliveira-Silva; Johannes H Dreyer; Victor José Ferreira Perrusi; Roberto Alfonso Arcuri; Rocio Hassan; Cibele Rodrigues Bonvicino; Mario Henrique M Barros; Gerald Niedobitek
Journal:  Virchows Arch       Date:  2015-03-28       Impact factor: 4.064

6.  [The visionary concept of "lymphoepithelioma" by A. Schmincke in 1921. Subsequent confusion over terminology and current approach to a solution].

Authors:  S Ihrler; O Guntinas-Lichius; M Mollenhauer
Journal:  Pathologe       Date:  2014-03       Impact factor: 1.011

7.  Presence of DNA of human papillomavirus 16 but no other types in tumor-free tonsillar tissue.

Authors:  Renwei Chen; Peter Sehr; Tim Waterboer; Ilmo Leivo; Michael Pawlita; Antti Vaheri; Leena-Maija Aaltonen
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

Review 8.  HPV infections and tonsillar carcinoma.

Authors:  S Syrjänen
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

Review 9.  [HPV-associated tonsillar cancer. An update].

Authors:  J P Klussmann; S Dinh; O Guntinas-Lichius; C Wittekindt; S Weissenborn; U Wieland; H P Dienes; T Hoffmann; E Smith; L Turek; E J M Speel; H J Pfister
Journal:  HNO       Date:  2004-03       Impact factor: 1.284

Review 10.  Replication and assembly of human papillomaviruses.

Authors:  M J Conway; C Meyers
Journal:  J Dent Res       Date:  2009-04       Impact factor: 6.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.